Status:
COMPLETED
Pharmacists Intervention to Improve Hypertension Management in Primary Care
Lead Sponsor:
Wilhelminenspital Vienna
Collaborating Sponsors:
Österreichische Apothekerkammer, Landesgeschäftsstelle Niederösterreich
Association for the Promotion of Research in Atherosclerosis, Thrombosis and Vascular Biology
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Arterial hypertension is the single largest contributor to mortality world-wide, and only 30-50% of diagnosed and treated patients achieve their blood pressure goal. The APOTHECARE trial is designed t...
Detailed Description
Patients with medically treated arterial hypertension, who attend a pharmacy in order to obtain their antihypertensive medication are invited to participate in the trial. The main inclusion criteria ...
Eligibility Criteria
Inclusion
- Written informed consent
- Age \> 18 years
- Medically pre-treated arterial hypertension
- Automated office blood pressure ≥ 135 mmHg systolic or ≥ 85 mmHg diastolic
Exclusion
- First ever prescription of antihypertensive medication
- First prescription of a new antihypertensive substance or dose adjustment
- Prior therapy with 4 or more different antihypertensive substances
- Systolic blood pressure ≥ 180 mmHg
- Dialysis
- Adherence to the study protocol not to be anticipated
- Inclusion into the study at another study site
Key Trial Info
Start Date :
October 16 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
497 Patients enrolled
Trial Details
Trial ID
NCT03274531
Start Date
October 16 2017
End Date
December 31 2019
Last Update
April 7 2020
Active Locations (54)
Enter a location and click search to find clinical trials sorted by distance.
1
Buchen-Apotheke
Alland, Austria, 2534
2
Apotheke Bad Erlach
Bad Erlach, Austria, 2822
3
Kur-Apotheke
Bad Vöslau, Austria, 2540
4
Landschafts-Apotheke
Baden, Austria, 2500